PERMANENT HEMODIALYSIS ADEQUACY AND EXTRACORPORAL AUTOHEMOMAGNETIC THERAPY IN PATIENTS WITH ESRD
https://doi.org/10.24884/1561-6274-2010-14-4-42-47
Abstract
THE AIM of the study was to assess the dynamics indices related to hemodialysis (HD) adequacy (including chronic inflammation factors, indices of the erythropoiesis) in patients with chronic kidney disease (CKD) at the stage of program haemodialysis from the point of view of the influence of extracorporeal autohemomagnetic therapy (EAHMT). PATIENTS AND METHODS. 88 patients (control-43, experiment-45) with ESRD were under 2-years observation. Course of EAHMT (6 procedures) was used during of a haemodialysis session and was repeated in 4 months. RESULTS. Significant elevation of Kt/V, URR, erythrocytes, hemoglobin, albumin, but ferritin plasma level was decreased after the course of EAHMT. CONCLUSION. Risk of the complications from disorders, related to ESRD, stresses the necessity of timely detection and adequate correction of them. Periodical courses of EAHMT can be included in traditional treatment in ESRD patients, and also to low such a risk and to elevate permanent haemodialysis adequacy.
About the Authors
S. A. SavostiyanickBelarus
V. V. Spas
Belarus
R. E. Yakubtsevich
Belarus
L. C. Dobrenko
Belarus
T. E. Yanulevich
Belarus
O. N. Borodavko
Belarus
References
1. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-534
2. Lim J, Gasson C, Kaji D. Urea inhibits NaK2Cl cotransport in human erythrocytes. J Clin Invest 1995; 96: 2126-2132
3. Monti J, Brunet P, Berland Y et al. Opposite effects of urea on hemoglobin-oxygen affinity in anemia in chronic renal failure. Kidney Int 1995; 48: 827-831
4. Owen W, Lew N, Liu Y et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006
5. Vanholder R, Ringoir S. Adequacy of dialysis: a critical analysis. Kidney Int 1992; 42: 540-558
6. Гусев ЕЮ, Соломатина ЛВ, Журавлева ЮА, Зубова ТЭ. Системная воспалительная реакция у больных с терминалоной хронической почечной недостаточностью. Нефрология и диализ 2008; 10 (3-4): 248-253
7. Zoccali C, Mallamaci F, Mass R et al. Left ventricular hypertrophy,cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 2002; 62: 339-345
8. Keith D, Nichols G, Gullion C et al. Mortality of chronic kidney disease in large HMO population. J Am Soc Nephrol 2002; 13: 620
9. Foley RN, Parfrey PS, Morgan J еt al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325-1335
10. Даугирдас ДжТ, Кьеллстранд КМ. Хронический гемодиализ: кинетическое моделирование мочевины. В: Даугирдас ДжТ, Блейк ПДж, Инг ТС, ред. Руководство по диализу, 3-е изд. Центр диализа, М., 2003; 144-171
11. Костюченко АЛ. Эфферентная терапия. СПб., 2000; 11-140
12. Лужников ЕА, Гольдфарб ЮС. Физиогемотерапия острых отравлений. М., 2002; 200
13. Камышников ВС. Справочник по клинико-биохимической диагностике. Беларусь, Минск, 2000; 1: 346-347
14. Остапенко ВА, Плетнев СВ. Биологическое действие магнитных полей. Эфферентная терапия 2004; 10 (4): 21-24
15. Ciejka E. The effects of low magnetic field on select parameters of blood coagulation. Pol. Merekuriusz Lek 2005; 110 (19): 148-151
16. Gunnell J. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33: 63-72
Review
For citations:
Savostiyanick S.A., Spas V.V., Yakubtsevich R.E., Dobrenko L.C., Yanulevich T.E., Borodavko O.N. PERMANENT HEMODIALYSIS ADEQUACY AND EXTRACORPORAL AUTOHEMOMAGNETIC THERAPY IN PATIENTS WITH ESRD. Nephrology (Saint-Petersburg). 2010;14(4):42-47. (In Russ.) https://doi.org/10.24884/1561-6274-2010-14-4-42-47